The Salgi Esophageal Cancer Research Foundation

Little Company of Mary Hospital and Health Care Centers, a Catholic, not-for-profit hospital based in Evergreen Park, Illinois offers patients with Barrett’s esophagus a new tool to treat the disease.

“HALO 360 Ablation Therapy System” uses radiofrequency energy to destroy the precancerous tissue of the esophagus. If left untreated, the precancerous tissue can lead to esophageal cancer.

Dr. Brian Blumenstein, board-certified gastroenterologist at Little Company of Mary, stated in a press release that “Barrett’s esophagus affects nearly two million Americans and is the leading cause of esophageal cancer.”

“Esophageal cancer is one of the fastest growing and deadly forms of cancer in the United States today” said Blumenstein.

“Radiofrequency ablation allows us to destroy and remove the diseased tissue without harming healthy, underlying structures of the esophagus,” Dr. Blumenstein stated. “There’s minimal scarring, and the risk for complications is very low.”

The American Gastroenterological Association issued new guidelines that support the use of radiofrequency ablation for individuals with Barrett’s esophagus.

To read more about HALO Treatment, click here.

This entry was posted on Thursday, January 12th, 2012 at 7:34 pm and is filed under The Salgi Foundation - Esophageal Cancer Awareness, Early Detection & Research. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.